AT1 14.3% 2.4¢ atomo diagnostics limited

Buckle up for $1, page-202

  1. 407 Posts.
    lightbulb Created with Sketch. 46
    Access Bio's newly developed blood-based IgG/IgM diagnostic test detects antibodiesproduced in response to infection by COVID-19. Access Bio’s standard test kit format received an Emergency Use Authorisation1 (EUA) by the US Food & Drug Administration(FDA) on 24 July 2020

    Access Bio already have approval for their standard device but yet they are still wanting to uses Atomo's device so even if it was the same type of test there is still demand.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.003(14.3%)
Mkt cap ! $15.34M
Open High Low Value Volume
2.1¢ 2.4¢ 2.1¢ $13.07K 607.5K

Buyers (Bids)

No. Vol. Price($)
1 405 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 277040 4
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.